Advanced search
1 file | 322.30 KB Add to list

Venture capitalists' selection process: the case of biotechnology proposals

Author
Organization
Abstract
The paper analyses venture capitalists' (VCs) selection process in biotechnology ventures. Biotech ventures operate in an extremely risky environment making this an interesting research setting. The majority of venture capitalists exclude certain biotech sectors ex-ante because of regulatory uncertainty, the long development process to a market-ready product and the difficulty to understand the technology. The more thorough due diligence process focuses on financial, market and technology criteria. Management team capabilities are more important for later stage investors, whereas early stage investors expect to have an impact on the future recruiting of professional managers. Despite the higher risk of biotech investments, we find no evidence that VCs require higher hurdle rates or more complete contracts for these investments, compared to investments in other technology-based companies. The most important reason for not reaching an investment agreement is disagreement over valuation, due to large differences in risk perception between entrepreneurs and venture capitalists and the lack of a standard valuation tool for biotech projects.
Keywords
INVESTMENT DECISION, BIAS, venture capital, selection process, biotechnology, MODEL, MARKET, FIRMS, CONTRACTS

Downloads

  • 8618766.pdf
    • full text
    • |
    • open access
    • |
    • PDF
    • |
    • 322.30 KB

Citation

Please use this url to cite or link to this publication:

MLA
Baeyens, Katleen, Tom Vanacker, and Sophie Manigart. “Venture Capitalists’ Selection Process: The Case of Biotechnology Proposals.” INTERNATIONAL JOURNAL OF TECHNOLOGY MANAGEMENT 34.1-2 (2006): 28–46. Print.
APA
Baeyens, K., Vanacker, T., & Manigart, S. (2006). Venture capitalists’ selection process: the case of biotechnology proposals. INTERNATIONAL JOURNAL OF TECHNOLOGY MANAGEMENT, 34(1-2), 28–46.
Chicago author-date
Baeyens, Katleen, Tom Vanacker, and Sophie Manigart. 2006. “Venture Capitalists’ Selection Process: The Case of Biotechnology Proposals.” International Journal of Technology Management 34 (1-2): 28–46.
Chicago author-date (all authors)
Baeyens, Katleen, Tom Vanacker, and Sophie Manigart. 2006. “Venture Capitalists’ Selection Process: The Case of Biotechnology Proposals.” International Journal of Technology Management 34 (1-2): 28–46.
Vancouver
1.
Baeyens K, Vanacker T, Manigart S. Venture capitalists’ selection process: the case of biotechnology proposals. INTERNATIONAL JOURNAL OF TECHNOLOGY MANAGEMENT. 2006;34(1-2):28–46.
IEEE
[1]
K. Baeyens, T. Vanacker, and S. Manigart, “Venture capitalists’ selection process: the case of biotechnology proposals,” INTERNATIONAL JOURNAL OF TECHNOLOGY MANAGEMENT, vol. 34, no. 1–2, pp. 28–46, 2006.
@article{413066,
  abstract     = {The paper analyses venture capitalists' (VCs) selection process in biotechnology ventures. Biotech ventures operate in an extremely risky environment making this an interesting research setting. The majority of venture capitalists exclude certain biotech sectors ex-ante because of regulatory uncertainty, the long development process to a market-ready product and the difficulty to understand the technology. The more thorough due diligence process focuses on financial, market and technology criteria. Management team capabilities are more important for later stage investors, whereas early stage investors expect to have an impact on the future recruiting of professional managers. Despite the higher risk of biotech investments, we find no evidence that VCs require higher hurdle rates or more complete contracts for these investments, compared to investments in other technology-based companies. The most important reason for not reaching an investment agreement is disagreement over valuation, due to large differences in risk perception between entrepreneurs and venture capitalists and the lack of a standard valuation tool for biotech projects.},
  author       = {Baeyens, Katleen and Vanacker, Tom and Manigart, Sophie},
  issn         = {0267-5730},
  journal      = {INTERNATIONAL JOURNAL OF TECHNOLOGY MANAGEMENT},
  keywords     = {INVESTMENT DECISION,BIAS,venture capital,selection process,biotechnology,MODEL,MARKET,FIRMS,CONTRACTS},
  language     = {eng},
  number       = {1-2},
  pages        = {28--46},
  title        = {Venture capitalists' selection process: the case of biotechnology proposals},
  url          = {http://dx.doi.org/10.1504/IJTM.2006.009446},
  volume       = {34},
  year         = {2006},
}

Altmetric
View in Altmetric
Web of Science
Times cited: